Common antidepressants in pregnancy may alter fetal brain development

April 10, 2018 by Alan Mozes, Healthday Reporter

(HealthDay)—Pregnant women who take certain antidepressants may unknowingly compromise the brain development of their child, researchers suggest.

The concern is based on a new analysis of scans involving nearly 100 newborns, some of whom were born to mothers who took selective serotonin reuptake inhibitors (SSRIs) while pregnant. Some examples of SSRIs are Zoloft, Lexapro, Celexa and Prozac.

The scans indicated that SSRI exposure in the womb was associated with an increase in the size of gray matter found in two parts of the brain: the amygdala and the insula. Maternal SSRI use was also linked to an increase in white matter connections between the two regions.

Animal research has linked such increases to a higher risk for developing anxiety and , explained study author Jiook Cha, an assistant professor in the division of child and adolescent psychiatry at Columbia University Medical Center in New York City.

What's more, the changes Cha and his colleagues saw were "much greater than the brain changes or abnormalities associated with psychiatric disorders that we usually observe in children or adults," he said.

Still, Cha noted that the study "does not demonstrate cause and effect." And he added that his team "did not test long-term consequences of the brain changes associated with prenatal exposure to SSRIs."

But Cha stressed that the association "may make it difficult to think prenatal exposure to SSRIs may have no impact on development."

Generally speaking, gray matter facilitates most of the brain's signaling and is central to sensory perceptions, while white matter is largely nerve fiber bundles that enable communication between brain regions. The specific brain regions in question are critical to the processing of emotions.

All the mothers in the study were between the ages of 18 and 45 while pregnant between 2011 and 2016. Nearly a third were white, a quarter Hispanic, and a quarter black.

Most of the mothers had been examined for depression before, during and after pregnancy, and those prescribed an SSRI during their pregnancy were assigned to the "SSRI group."

All of the newborns had brain scans at an average age of just 1.5 weeks.

The scans revealed that babies in the SSRI group had "significant" increases in the size of amygdala and insula , compared with those born to mothers who had been diagnosed with depression but not given an SSRI and those born to moms without depression.

SSRI group infants also had "a significant increase" in white matter connections between those two regions, relative to the other groups.

Cha noted that while maternal depression (with or without SSRI treatment) was accounted for, the study did not examine other critical factors that could affect fetal development, including a family history of depression.

He also said more and larger investigations will be needed to see how fetal linked to maternal SSRI use might translate into mental health difficulties later in life.

In the meantime, what should pregnant women struggling with depression do?

"Unfortunately right now, based on the study, we cannot advise mothers and their doctors on whether to start or continue SSRIs through pregnancy," said Cha. "For now, each mother and their team of doctors should discuss the pros and cons of medication, and choose the option that makes the most sense for their particular situation."

But Dr. Nada Stotland, past president of the American Psychiatry Association and a professor of psychiatry at Rush Medical College in Chicago, characterized the finding as "interesting, but extremely preliminary." She was not involved with the study.

"Implying this association between fetal brain region development with how a child is going to behave for the rest of his life is very premature," she said. "And it's something we never hear said about other medications that pregnant women take all the time for asthma, or heart disease or diabetes.

"Of course, no medication can ever be proven to be absolutely safe for the unborn child," Stotland acknowledged. "But we do know that untreated depression is a risk for the pregnancy, the fetus and the newborn. So this doesn't belong in the public sphere, because it will alarm people unnecessarily."

Explore further: Maternal use of SSRIs associated with fewer depressive symptoms, delayed fetal head growth

More information: Jiook Cha, Ph.D., assistant professor, division of child and adolescent psychiatry, Columbia University Medical Center, New York City; Nada Stotland, M.D., M.P.H., past president, American Psychiatry Association, and professor, psychiatry, and obstetrics/gynecology, Rush Medical College, Chicago; April 9, 2018, JAMA Pediatrics, Abstract/Full Text

There's more on SSRIs and pregnancy risks at U.S. Centers for Disease Control and Prevention.

Related Stories

Maternal use of SSRIs associated with fewer depressive symptoms, delayed fetal head growth

March 5, 2012
Treating pregnant women with selective serotonin reuptake inhibitors (SSRIs) appears to be associated with fewer depressive symptoms, reduced fetal head growth and a higher risk for preterm birth, but not with a delay in ...

Antidepressants during pregnancy associated with childhood language disorders

October 12, 2016
Mothers who purchased antidepressants at least twice during pregnancy had a 37-percent increased risk of speech and/or language disorders among their offspring compared to mothers with depression and other psychiatric disorders ...

Gestational exposure to type of antidepressants associated with adolescent depression

April 28, 2016
A study to be published in the May 2016 issue of the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) reports that use of certain antidepressants during pregnancy can result in offspring depression ...

Antidepressant use in pregnancy may be associated with structural changes in the infant brain

May 20, 2014
(Medical Xpress)—A new study by University of North Carolina at Chapel Hill researchers found that children of depressed mothers treated with a group of antidepressants called selective serotonin reuptake inhibitors (SSRIs) ...

Infants exposed to SSRI antidepressants are more likely to have decreased birth weight

May 17, 2016
A new study, published today in the International Journal of Epidemiology, has found that prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) has a significant association with lower birth weight and gestational ...

Antidepressant use during pregnancy not linked to autism

December 19, 2013
(HealthDay)—Despite some concerns to the contrary, children whose moms used antidepressants during pregnancy do not appear to be at increased risk of autism, a large new Danish study suggests.

Recommended for you

People with family history of alcoholism release more dopamine in expectation of alcohol

May 23, 2018
People with a family history of alcohol use disorder (AUD) release more dopamine in the brain's main reward center in response to the expectation of alcohol than people diagnosed with the disorder, or healthy people without ...

Why we fail to understand our smartphone use

May 23, 2018
Checking your phone dozens of times a day indicates unconscious behaviour, which is "extremely repetitive" say psychologists.

Study confirms that men and women tend to adopt different navigation strategies

May 23, 2018
When navigating in a known environment, men prefer to take shortcuts to reach their destination more quickly, while women tend to use routes they know. This is according to Alexander Boone of UC Santa Barbara in the US who ...

App helps hearing-impaired parents know when and why their baby is crying

May 23, 2018
For parents Delbert and Sanaz Whetter a crying baby is a particularly difficult challenge. The Whetters are deaf, so when they're in another room they rely on cameras and remote noise-monitors to help keep an eye on their ...

Early life trauma in men associated with reduced levels of sperm microRNAs

May 22, 2018
Exposure to early life trauma can lead to poor physical and mental health in some individuals, which can be passed on to their children. Studies in mice show that at least some of the effects of stress can be transmitted ...

Training compassion 'muscle' may boost brain's resilience to others' suffering

May 22, 2018
It can be distressing to witness the pain of family, friends or even strangers going through a hard time. But what if, just like strengthening a muscle or learning a new hobby, we could train ourselves to be more compassionate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.